Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic

por Frost, Madeline C., Zhang, Lan, Kim, H. Myra, Lin, Lewei (Allison)
Publicado 2022

Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder

por Haffajee, Rebecca L., Lin, Lewei Allison, Bohnert, Amy S. B., Goldstick, Jason E.
Publicado 2019

3142 U.S. Counties with High Opioid-Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder: an Observational Study

por Haffajee, Rebecca, Lin, Lewei Allison, Bohnert, Amy S.B., Goldstick, Jason E.
Publicado 2019

Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder

por Christine, Paul J., Larochelle, Marc R., Lin, Lewei (Allison), McBride, Jonathon, Tipirneni, Renuka
Publicado 2023

Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries

por Maust, Donovan T., Lin, Lewei Allison, Goldstick, Jason E., Haffajee, Rebecca L., Brownlee, Rebecca, Bohnert, Amy S. B.
Publicado 2020

Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States

por Lin, Chunqing, Pham, Huyen, Zhu, Yuhui, Clingan, Sarah E., Lin, Lewei (Allison), Murphy, Sean M., Campbell, Cynthia I., Sorrell, Tanya R., Liu, Yanping, Mooney, Larissa J., Hser, Yih-Ing
Publicado 2023